NCT04739761 - A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer | Biotech Hunter

Enrollment

506

Participants

Timeline

Start Date

June 22, 2021

Primary Completion Date

February 8, 2024

Study Completion Date

February 3, 2026

Conditions

Breast Cancer

Interventions

DRUG

Trastuzumab Deruxtecan

Participants will receive T-DXd administered using an IV bag containing 5% (w/v) dextrose injection infusion solution.

Trial Locations (81)

7

Research Site, Dublin

450

Research Site, Oslo

1011

Research Site, Lausanne

1070

Research Site, Anderlecht

1307

Research Site, Dresden

2065

Research Site, St Leonards

2100

Research Site, Copenhagen

2730

Research Site, Herlev

3000

Research Site, Leuven

3084

Research Site, Heidelberg

3168

Research Site, Clayton

4000

Research Site, Liège

4031

Research Site, Basel

4066

Research Site, Auchenflower

5000

Research Site, Adelaide

Research Site, Odense C

5009

Research Site, Bergen

6000

Research Site, Lucerne

6008

Research Site, Subiaco

8000

Research Site, Bruges

8035

Research Site, Barcelona

13125

Research Site, Berlin

15706

Research Site, Santiago de Compostela-Coruña

18014

Research Site, Granada

20132

Research Site, Milan

20246

Research Site, Hamburg

20520

Research Site, Turku

24105

Research Site, Kiel

24127

Research Site, Bergamo

27710

Research Site, Durham

28005

Research Site, Madrid

28034

Research Site, Madrid

28041

Research Site, Madrid

30625

Research Site, Hanover

35128

Research Site, Padua

37007

Research Site, Salamanca

39008

Research Site, Santander

41013

Research Site, Seville

45136

Research Site, Essen

46009

Research Site, Valencia

48013

Research Site, Bilbao (Vizcaya)

48149

Research Site, Münster

59100

Research Site, Prato

60122

Research Site, Ancona

60389

Research Site, Frankfurt

68167

Research Site, Mannheim

72076

Research Site, Tübingen

80131

Research Site, Napoli

80336

Research Site, München

80637

Research Site, München

91054

Research Site, Erlangen

95126

Research Site, Catania

02215

Research Site, Boston

V5Z 1H7

Research Site, Vancouver

M4N 3M5

Research Site, Toronto

00290

Research Site, Helsinki

FI-33521

Research Site, Tampere

T12 DV56

Research Site, Cork

D04 Y8V0

Research Site, Dublin

259-1193

Research Site, Isehara

216-8511

Research Site, Kawasaki-shi

003-0804

Research Site, Sapporo

142-8666

Research Site, Shinagawa-ku

241-8515

Research Site, Yokohama

6229 HX

Research Site, Maastricht

2545 AA

Research Site, The Hague

N-0379

Research Site, Oslo

80-214

Research Site, Gdansk

31-501

Research Site, Krakow

45-060

Research Site, Opole

02-781

Research Site, Warsaw

04-141

Research Site, Warsaw

1400-048

Research Site, Lisbon

1649-035

Research Site, Lisbon

4099-001

Research Site, Porto

08036

Research Site, Barcelona

413 45

Research Site, Gothenburg

221 85

Research Site, Lund

751 85

Research Site, Uppsala

CH-6500

Research Site, Bellinzona

EH4 2XR

Research Site, Edinburgh